ARGX logo

argenx SE (ARGX) Company Overview

Profile

Full Name:

argenx SE

Sector:

Healthcare

Industry:

Biotechnology

Country:

Netherlands

IPO:

May 18, 2017

Indexes:

Not included

Description:

Argenx SE is a biotechnology company focused on developing innovative therapies for autoimmune diseases and cancer. They use their unique antibody platform to create treatments that target specific proteins in the immune system, aiming to improve patient outcomes and quality of life.

Key Details

Price

$592.00

Annual Revenue

$2.19 B(+78.60% YoY)

Annual EPS

$12.78(+347.67% YoY)

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 Baird
Neutral
Feb 28, 25 Wells Fargo
Overweight
Feb 28, 25 Oppenheimer
Outperform
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Citizens Capital Markets
Outperform
Jan 14, 25 Truist Securities
Buy
Jan 14, 25 JMP Securities
Market Outperform
Jan 14, 25 HC Wainwright & Co.
Buy
Jan 7, 25 Piper Sandler
Overweight
Dec 19, 24 Wells Fargo
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for argenx SE?
  • Does argenx SE pay dividends?
  • What sector is argenx SE in?
  • What industry is argenx SE in?
  • What country is argenx SE based in?
  • When did argenx SE go public?
  • Is argenx SE in the S&P 500?
  • Is argenx SE in the NASDAQ 100?
  • Is argenx SE in the Dow Jones?
  • When was argenx SE's last earnings report?
  • When does argenx SE report earnings?
  • Should I buy argenx SE stock now?

What is the ticker symbol for argenx SE?

The ticker symbol for argenx SE is NASDAQ:ARGX

Does argenx SE pay dividends?

No, argenx SE does not pay dividends

What sector is argenx SE in?

argenx SE is in the Healthcare sector

What industry is argenx SE in?

argenx SE is in the Biotechnology industry

What country is argenx SE based in?

argenx SE is headquartered in Netherlands

When did argenx SE go public?

argenx SE's initial public offering (IPO) was on May 18, 2017

Is argenx SE in the S&P 500?

No, argenx SE is not included in the S&P 500 index

Is argenx SE in the NASDAQ 100?

No, argenx SE is not included in the NASDAQ 100 index

Is argenx SE in the Dow Jones?

No, argenx SE is not included in the Dow Jones index

When was argenx SE's last earnings report?

argenx SE's most recent earnings report was on Feb 27, 2025

When does argenx SE report earnings?

The next expected earnings date for argenx SE is May 8, 2025

Should I buy argenx SE stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions